April 23, 2026

🚀 2 patients were successfully treated last week at Hôpital Européen Georges-Pompidou (HEGP) with Valvosoft®, following its CE marking ✅
 
🏥 This achievement represents an important step as Valvosoft® enters routine clinical use in Europe and highlights the close collaboration between innovative medtech teams and leading clinical centers.
 
🌍 Over the coming months, Valvosoft® will be deployed in several hospitals:
🇫🇷 4 in France, 🇩🇪 2 in Germany, and 🇳🇱 1 in the Netherlands.
 
🙏 We would like to sincerely thank the medical and hospital teams at HEGP for their trust and commitment, as well as everyone who contributed to making this milestone possible.
 
#StructuralHeart #Innovation #AorticStenosis #CardiovascularInnovation #Valvosoft #medtech #focusedultrasound #innovation #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #valves #CEMarking
 
@AP‑HP, Assistance Publique – Hôpitaux de Paris #HEGP, @Physics for Medicine Paris, #InstitutLangevin, @CNRS, @ESPCI Paris – PSL, @Inserm @RHU_STOP_AS
 
#FrenchCare #Health20 @france-biotech @medicen-paris-region @bpi-france @focusedultrasoundfoundation @eic-scalingclub @snitem